Pharmacological modulation of beta-catenin and its applications in cancer therapy
about
Structural Analysis of the 14-3-3ζ/Chibby Interaction Involved in Wnt/β-Catenin SignalingCasein kinase 1 α phosphorylates the Wnt regulator Jade-1 and modulates its activityTranscriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.Tumour suppressor TRIM33 targets nuclear β-catenin degradationRepurposing the antipsychotic trifluoperazine as an antimetastasis agent.Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loopTransmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness.The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk.Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells.An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.Curcumin inhibits bladder cancer progression via regulation of β-catenin expression.Intracellular Osteopontin Induced by CagA-positive Helicobacter pylori Promotes Beta-catenin Accumulation and Interleukin-8 Secretion in Gastric Epithelial cells.Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells.Identification of proteins related to epigenetic regulation in the malignant transformation of aberrant karyotypic human embryonic stem cells by quantitative proteomics.E-Cadherin/β-Catenin Complex: A Target for Anticancer and Antimetastasis Plants/Plant-derived Compounds.Identification and characterization of PKF118-310 as a KDM4A inhibitor.Diabetic Retinopathy and Laser Therapy in Rats: A Protein-Protein Interaction Network Analysis.Evaluation of the interaction between proliferation, oxidant-antioxidant status, Wnt pathway, and apoptosis in zebrafish embryos exposed to silver nanoparticles used in textile industry.Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.Sesterterpenoid and Steroid Metabolites from a Deep-Water Alaska Sponge Inhibit Wnt/β-Catenin Signaling in Colon Cancer Cellsmethanolic extract triggers apoptosis in HepG2 cells
P2860
Q21131783-9808B44A-8016-40F7-9F2B-587C0A641DA7Q28245461-748488B4-AC77-4444-BB15-A5DC65027AF2Q33567714-D665E08A-AA03-413E-ADD0-F2DA6CEA7798Q33648449-5D7BF974-3967-48AD-B686-4BDBA2FE6F45Q33827178-EEB4B22C-7E8C-4108-B2A6-B21446A77CE3Q33848094-094CE5B1-96D3-41DA-992E-96A36D2A5DB0Q35043217-992634CE-0C21-46C8-9E1D-612BC042B1CDQ35536672-B230C27C-D07D-4227-9164-4EA02D5A5553Q35654152-3E0B0FB0-90CA-4008-98C1-54F37C8201F0Q35745099-E7F0701D-E130-495A-8B35-71088425AEF0Q35905777-3C07ADC5-A842-4A49-B075-EE03505D7000Q36009814-4691AB8A-7220-40C2-A18D-8243FCEED182Q37290566-A29569D4-FB6B-49F2-86D9-895ED5C708A1Q37319857-93ADAA21-D15D-4445-86CE-EBEA464C4B9CQ37536551-4F0DC444-3735-466C-954A-64D96A0CE69CQ37603293-33EB6A43-AE73-493F-9E28-668E27743B0EQ37609400-36CF9F0D-0BBA-40CD-9715-682D7D6A4192Q37649280-C25E6931-A9AB-4333-BECE-8129344FF867Q38697407-8E0376BF-7AE7-453C-B3F5-19333C1AE631Q38904180-E2B59DDE-B1F8-4037-B223-1192610A0FCDQ38910924-09574046-AB57-47ED-82E2-6AF6C1BDEBAAQ39030316-BBAFCCD3-D210-494D-B1C4-B514AEE4E72DQ39317906-BCC94158-E069-4459-8213-B54DDAB3382FQ42358298-E9A73828-41FA-432C-9795-34B5EBB1BD47Q42699559-6B6ED5D1-FE98-4E7A-9B1C-CB972397E8B4Q47214806-CA93BFE1-0B00-43DC-92B9-F37C2E575069Q47712719-CD61529F-8987-4748-A87B-73424F7DDC6BQ48221145-B4BAD83E-BB36-4276-911C-242962165C79Q49243252-F4B688A6-9E0E-4FC4-B2A2-E854DC178A3BQ50098159-C6F783DE-8FA5-493E-9397-0408FFEC051DQ51017220-A3157FD9-75FF-493A-A1CD-8CF3B0C7FE2EQ52331241-56F5598C-2CF8-4133-9A7E-54C54B4DF64DQ58700110-EEADDE7E-6330-4063-9F1A-ECEDA137F8F8Q59129544-5536D165-6DA3-4134-93B9-4C101CBE0277
P2860
Pharmacological modulation of beta-catenin and its applications in cancer therapy
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological modulation of beta-catenin and its applications in cancer therapy
@en
type
label
Pharmacological modulation of beta-catenin and its applications in cancer therapy
@en
prefLabel
Pharmacological modulation of beta-catenin and its applications in cancer therapy
@en
P2860
P921
P356
P1476
Pharmacological modulation of beta-catenin and its applications in cancer therapy
@en
P2093
Durga Prasad Mishra
Ravi Thakur
P2860
P304
P356
10.1111/JCMM.12033
P5008
P577
2013-03-14T00:00:00Z
2013-04-01T00:00:00Z